147 related articles for article (PubMed ID: 12356836)
1. Termination of experimental galactosemia in rats, and progression of retinal metabolic abnormalities.
Kowluru RA; Koppolu P
Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3287-91. PubMed ID: 12356836
[TBL] [Abstract][Full Text] [Related]
2. Abnormalities of retinal metabolism in diabetes or experimental galactosemia VIII. Prevention by aminoguanidine.
Kowluru RA; Engerman RL; Kern TS
Curr Eye Res; 2000 Oct; 21(4):814-9. PubMed ID: 11120572
[TBL] [Abstract][Full Text] [Related]
3. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia.
Kern TS; Tang J; Mizutani M; Kowluru RA; Nagaraj RH; Romeo G; Podesta F; Lorenzi M
Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3972-8. PubMed ID: 11053301
[TBL] [Abstract][Full Text] [Related]
4. Subnormal retinal oxygenation response precedes diabetic-like retinopathy.
Berkowitz BA; Kowluru RA; Frank RN; Kern TS; Hohman TC; Prakash M
Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2100-5. PubMed ID: 10440266
[TBL] [Abstract][Full Text] [Related]
5. Effect of galactose diet removal on the progression of retinal vessel changes in galactose-fed dogs.
Kador PF; Takahashi Y; Akagi Y; Neuenschwander H; Greentree W; Lackner P; Blessing K; Wyman M
Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1916-21. PubMed ID: 12036999
[TBL] [Abstract][Full Text] [Related]
6. Abnormalities of retinal metabolism in diabetes or galactosemia: ATPases and glutathione.
Kern TS; Kowluru RA; Engerman RL
Invest Ophthalmol Vis Sci; 1994 Jun; 35(7):2962-7. PubMed ID: 8206713
[TBL] [Abstract][Full Text] [Related]
7. Correction of early subnormal superior hemiretinal DeltaPO(2) predicts therapeutic efficacy in experimental diabetic retinopathy.
Berkowitz BA; Ito Y; Kern TS; McDonald C; Hawkins R
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2964-9. PubMed ID: 11687543
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effect of zeaxanthin on retinal metabolic abnormalities in diabetic rats.
Kowluru RA; Menon B; Gierhart DL
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1645-51. PubMed ID: 18385086
[TBL] [Abstract][Full Text] [Related]
9. Retinal metabolic abnormalities in diabetic mouse: comparison with diabetic rat.
Kowluru RA
Curr Eye Res; 2002 Feb; 24(2):123-8. PubMed ID: 12187484
[TBL] [Abstract][Full Text] [Related]
10. Redox-dependent effects of nitric oxide on microvascular integrity in oxygen-induced retinopathy.
Beauchamp MH; Sennlaub F; Speranza G; Gobeil F; Checchin D; Kermorvant-Duchemin E; Abran D; Hardy P; Lachapelle P; Varma DR; Chemtob S
Free Radic Biol Med; 2004 Dec; 37(11):1885-94. PubMed ID: 15528047
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of treatment after measurable diabeticlike retinopathy in galactose-fed rats.
Robison WG; Laver NM; Jacot JL; Chandler ML; York BM; Glover JP
Invest Ophthalmol Vis Sci; 1997 May; 38(6):1066-73. PubMed ID: 9152226
[TBL] [Abstract][Full Text] [Related]
12. Effect of curcumin on galactose-induced cataractogenesis in rats.
Suryanarayana P; Krishnaswamy K; Reddy GB
Mol Vis; 2003 Jun; 9():223-30. PubMed ID: 12802258
[TBL] [Abstract][Full Text] [Related]
13. Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy.
Kowluru RA; Tang J; Kern TS
Diabetes; 2001 Aug; 50(8):1938-42. PubMed ID: 11473058
[TBL] [Abstract][Full Text] [Related]
14. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. III. Effects of antioxidants.
Kowluru RA; Kern TS; Engerman RL; Armstrong D
Diabetes; 1996 Sep; 45(9):1233-7. PubMed ID: 8772728
[TBL] [Abstract][Full Text] [Related]
15. Effect of reinstitution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic rats.
Kowluru RA
Diabetes; 2003 Mar; 52(3):818-23. PubMed ID: 12606525
[TBL] [Abstract][Full Text] [Related]
16. Diabetes-induced activation of nuclear transcriptional factor in the retina, and its inhibition by antioxidants.
Kowluru RA; Koppolu P; Chakrabarti S; Chen S
Free Radic Res; 2003 Nov; 37(11):1169-80. PubMed ID: 14703729
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide synthases modulate progenitor and resident endothelial cell behavior in galactosemia.
Ellis EA; Sengupta N; Caballero S; Guthrie SM; Mames RN; Grant MB
Antioxid Redox Signal; 2005; 7(11-12):1413-22. PubMed ID: 16356104
[TBL] [Abstract][Full Text] [Related]
18. Drug intervention can correct subnormal retinal oxygenation response in experimental diabetic retinopathy.
Berkowitz BA; Roberts R; Luan H; Peysakhov J; Knoerzer DL; Connor JR; Hohman TC
Invest Ophthalmol Vis Sci; 2005 Aug; 46(8):2954-60. PubMed ID: 16043871
[TBL] [Abstract][Full Text] [Related]
19. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. VI. Comparison of retinal and cerebral cortex metabolism, and effects of antioxidant therapy.
Kowluru RA; Engerman RL; Kern TS
Free Radic Biol Med; 1999 Feb; 26(3-4):371-8. PubMed ID: 9895229
[TBL] [Abstract][Full Text] [Related]
20. [The effect of nitrogen monoxide and its synthase on the diabetic retinal damage].
Liu QH; Xie P; Ge YB; Yuan XR
Zhonghua Yan Ke Za Zhi; 2005 Sep; 41(9):837-41. PubMed ID: 16191353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
